# Novo Nordisk s.r.o. > Czech business **Wikidata**: [Q101063922](https://www.wikidata.org/wiki/Q101063922) **Source**: https://4ort.xyz/entity/novo-nordisk-s-r-o ## Summary Novo Nordisk s.r.o. is a Czech business entity operating as a subsidiary of the global healthcare company Novo Nordisk. Incorporated on January 1, 1997, it is legally structured as a společnost s ručením omezením (limited liability company) and headquartered in Prague, Czech Republic. ## Key Facts - **Official Name:** Novo Nordisk s.r.o. - **Instance of:** Business (organization undertaking commercial, industrial, or professional activity) - **Inception:** January 1, 1997 - **Legal Form:** Společnost s ručením omezeným (Czech limited liability company) - **Parent Organization:** Novo Nordisk - **Headquarters:** Prague, Czech Republic (Address: Evropská 33c, Postal Code: 160 00) - **Czech Registration ID (IČO):** 25097750 - **OpenCorporates ID:** cz/25097750 - **Ringgold ID:** 155508 - **ISNI:** 0000000403912646 - **ISDS ID:** 9hsqnim - **Website:** http://www.novonordisk.cz - **Country:** Czech Republic ## FAQs **What is the legal structure of Novo Nordisk s.r.o.?** Novo Nordisk s.r.o. is registered as a "společnost s ručením omezeným," which is the Czech equivalent of a limited liability company (LLC). This structure limits the liability of its shareholders to their capital contributions. **Where is Novo Nordisk s.r.o. located?** The company is headquartered in Prague, the capital city of the Czech Republic. Its specific address is Evropská street 33c, with the postal code 160 00. **How can Novo Nordisk s.r.o. be identified in business registries?** It can be identified through its Czech Registration ID (IČO) 25097750, its OpenCorporates ID (cz/25097750), its Ringgold ID (155508), and its International Standard Name Identifier (ISNI) 0000000403912646. It also holds a Czech data box ID (ISDS ID) of 9hsqnim. **Who owns Novo Nordisk s.r.o.?** Novo Nordisk s.r.o. operates as a subsidiary of the parent company Novo Nordisk, which is a global healthcare company based in Denmark. ## Why It Matters Novo Nordisk s.r.o. serves as the local operating arm of its parent company within the Czech Republic, facilitating commercial activities and operations in the Central European market. As a business entity, it represents a direct economic link between the Czech Republic and the broader global pharmaceutical and healthcare industry led by Novo Nordisk. Its establishment in 1997 aligns with the period of economic development and foreign investment following the Velvet Revolution and the subsequent formation of the Czech Republic in 1993. Operating from the capital city of Prague, it plays a role in the local economy by participating in the Czech healthcare and commercial sectors, which are characterized by a high Human Development Index and a robust parliamentary republic system. ## Notable For - **Corporate Structure:** Being legally registered as a Czech "společnost s ručením omezeným" (limited liability company), aligning with local commercial laws. - **International Affiliation:** Serving as the official Czech subsidiary of Novo Nordisk, a major global healthcare organization. - **Location:** Being headquartered in Prague, the capital and largest city of the Czech Republic, situated in a country known for its high literacy rate (99%) and strong industrial base. - **Historical Context:** Having been founded on January 1, 1997, shortly after the peaceful dissolution of Czechoslovakia and the inception of the Czech Republic in 1993. ## Body ### Legal Entity and Classification Novo Nordisk s.r.o. is explicitly classified as a **business**, defined as an organization undertaking commercial, industrial, or professional activity. In the context of knowledge classification, a business is recognized as a juridical person and an economic entity, distinguished from broader concepts like "business activities" or "trading business" (Handelsgewerbe). As a juridical person, it operates legally within the framework of the Czech Republic, a sovereign state and parliamentary republic. The company's legal form is a **společnost s ručením omezeným**, which directly translates to a company with limited liability. This designation is common for commercial enterprises operating in the Czech Republic. Its official registered name is Novo Nordisk s.r.o. ### Corporate Hierarchy and Ownership Novo Nordisk s.r.o. is a direct subsidiary of its **parent organization**, Novo Nordisk. This relationship integrates the Czech entity into a larger global corporate structure. In the general theory of business organizations, ownership is typically attributed to entrepreneurs, and the primary goal of a business is to generate profit or economic profit. Novo Nordisk s.r.o. operates within this paradigm, utilizing components such as the enterprise, economic activity, property, and human capital. ### Geographical and Operational Base The entity is domiciled in the **Czech Republic**, a landlocked country in Central Europe. The Czech Republic was established on January 1, 1993, as a successor state to Czechoslovakia. The country operates on the Czech koruna (CZK) currency and is a member of the European Union, NATO, the United Nations, the OECD, and the Schengen Area. The headquarters of Novo Nordisk s.r.o. is located in **Prague**, the capital city of the Czech Republic. Detailed records specify the address as **Evropská 33c**, with the postal code **160 00**. Prague is situated within a nation that boasts a high Human Development Index (0.889 as of 2021) and a very low unemployment rate (2.4% as of May 2023). ### Company History and Timeline Novo Nordisk s.r.o. was officially established with an **inception date of January 1, 1997**. This places its founding roughly four years after the creation of the Czech Republic itself. The company maintains a web presence via its official website at **http://www.novonordisk.cz**. ### Registry Identifiers and Cataloging The company is tracked in multiple national and international databases, utilizing a range of unique persistent identifiers: * **Czech Registration ID (IČO):** 25097750 * **OpenCorporates ID:** cz/25097750 * **Ringgold ID:** 155508 (used for institutional identification) * **ISNI (International Standard Name Identifier):** 0000000403912646 * **ISDS ID:** 9hsqnim (Czech data box identifier for legal entities) * **Wikidata:** Described as a "Czech business." ### Broader Economic Context As a business operating within the Czech Republic, Novo Nordisk s.r.o. is part of an economy characterized by a nominal GDP of approximately $250 billion (2019). The nation supports a strong industrial base, particularly in sectors like engineering and manufacturing, and features a modern infrastructure that includes a right-hand traffic system, 230-volt electrical grids, and the country code +420. The Czech Republic is administratively divided into 14 regions, with Prague serving as both the capital and a significant economic hub bridging Western and Eastern Europe. ## References 1. Aligned ISNI and Ringgold identifiers for institutions 2. Access to Registers of Economic Subjects 3. [Seznam datových schránek : Právnické osoby. Ministry of the Interior](https://www.mojedatovaschranka.cz/sds/datafile?format=xml&service=seznam_ds_po)